Features | Partner Sites | Information | LinkXpress
Sign In
PZ HTL SA
GLOBETECH PUBLISHING LLC
GLOBETECH PUBLISHING LLC

Analytik Jena Acquires California-Based UVP

By BiotechDaily International staff writers
Posted on 30 Apr 2013
Analytik Jena, AG (Jena, Germany) recently acquired all of the outstanding shares of UVP, LLC (Upland, CA, USA), including its subsidiary, Ultra-Violet Products, Ltd. (Cambridge UK).

UVP is a leading manufacturer of bioimaging systems for applications in proteomics, genomics, animal and plant sciences. The company also develops ultraviolet (UV) products, light sources, and laboratory equipment such as hybridization ovens, transilluminators, crosslinkers, and polymerase chain reaction (PCR) hoods.

The acquisition of UVP allows Analytik Jena to strengthen its presence in the US market and expand its product range. “With the acquisition of UVP, we are significantly expanding our business activities in the Life Science unit and are laying an excellent basis for developing our successful business model in the US and neighboring regions. Here, we are combining efficient sales structures, a well-coordinated product portfolio, and broad technological expertise in the respective core segments. Further extensive synergies are to arise, especially in sales in Europe and Asia. With UVP, Analytik Jena also gains a production plant in the US dollar currency area,” remarked Klaus Berka, CEO of Analytik Jena, AG.

Analytik Jena is a provider of analytic technology, life-science systems for bioanalytic applications, and high-end optical consumer products. With UVP’s incorporation into Analytik Jena’s life-science business unit, many synergies are expected.

According to Leighton Smith, UVP’s president and CEO, “UVP has an opportunity to contribute significantly to the growth and profitability of Analytik Jena’s Life Science business unit. Our combined manufacturing expertise, portfolio of products and distribution channels open up new market opportunities, and begins an exciting new chapter in UVP’s history of providing innovative products and solutions to our customers.”

Related Links:

Analytik Jena
UVP



comments powered by Disqus

Channels

Genomics/Proteomics

view channel

New Program Encourages Wide Distribution of Genomic Data

A new data sharing program allows genomics researchers and practitioners to analyze, visualize, and share raw sequence data for individual patients or across populations straight from a local browser. The sequencing revolution is providing the raw data required to identify the genetic variants underlying rare diseases... Read more

Drug Discovery

view channel
Image: The nano-cocoon drug delivery system is biocompatible, specifically targets cancer cells, can carry a large drug load, and releases the drugs very quickly once inside the cancer cell. Ligands on the surface of the \"cocoon\" trick cancer cells into consuming it. Enzymes (the “worms\" in this image) inside the cocoon are unleashed once inside the cell, destroying the cocoon and releasing anticancer drugs into the cell (Photo courtesy of Dr. Zhen Gu, North Carolina State University).

Novel Anticancer Drug Delivery System Utilizes DNA-Based Nanocapsules

A novel DNA-based drug delivery system minimizes damage to normal tissues by utilizing the acidic microenvironment inside cancer cells to trigger the directed release of the anticancer drug doxorubicin (DOX).... Read more

Lab Technologies

view channel

Experimental Physicists Find Clues into How Radiotherapy Kills Cancer Cells

A new discovery in experimental physics has implications for a better determination of the process in which radiotherapy destroys cancer cells. Dr. Jason Greenwood from Queen’s University Belfast (Ireland) Center for Plasma Physics collaborated with scientists from Italy and Spain on the work on electrons, and published... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.